• Toronto housing ends 2025 on downswing, but recovery could come this year: board
• Novo Nordisk considers competing with generics through renamed lower-price Ozempic
• In the news: G7 discusses U.S. moves in Venezuela, RCAF growing despite challenges
• How Canadian agencies are embracing AI tools to defend national security
• Commander says RCAF is on a 'path of growth' in 2026